<?xml version="1.0" encoding="UTF-8"?>
<p id="para310">29 of 3489 participants who initiated PrEP had serious adverse events, including seven deaths (
 <xref rid="tbl5" ref-type="table">table 5</xref>, 
 <xref rid="sec1" ref-type="sec">appendix p 7</xref>). Five adverse events (all grade 3) were assessed as being possibly related to the study drug. One grade 3 creatinine elevation occurred in a 71-year-old man who was treated in hospital for urinary retention and hydronephrosis. Creatinine returned to baseline following relief of urinary obstruction and cessation of the study drug.
</p>
